drugset / Trial / NCT02742675
Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)
RandomizedParallel-groupOpen-labelTreatment
Summary
The goal of this clinical research is to learn if treatment with androgen deprivation therapy in combination with surgery or radiation therapy can prolong the progression-free survival of oligometastatic prostate cancer than androgen deprivation therapy alone. The safety of this treatment combination will also be studied.
Timeline
- Start
- 2015-09
- Primary completion
- 2021-03
- Completion
- 2023-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Bicalutamide | Other / unclassified | — | Oral |
| Background | Goserelin | Other / unclassified | — | Subcutaneous |
| Background | Leuprolide | Other / unclassified | — | Subcutaneous |
| Background | Triptorelin | Other / unclassified | — | Subcutaneous |
| Background | flutamide | Small molecule | — | Oral |